Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing luliconazole 2% cream versus ketoconazole 1% cream for pityriasis versicolor; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole 1% cream (ketoconazole)
  • Luliconazole 2% cream (luliconazole)

Snippet

Sponsor: PAEC General Hospital, Islamabad | Conditions: Pityriasis Versicolor | Phase 4 | Status: NOT_YET_RECRUITING